The Journal of the American Board of Family Medicine, with ISSN 1557-2625 and E-ISSN 1558-7118, is a prestigious publication dedicated to advancing the field of family medicine. Published by the American Board of Family Medicine, this journal has established itself as a vital resource for researchers, practitioners, and students interested in both family practice and public health. As of 2023, it boasts impressive rankings, being in the Q1 category of Family Practice and the Q2 category of Public Health, Environmental and Occupational Health according to Scopus metrics, reflecting its significant impact and influence in the academic community. The journal's focus on high-quality research ensures that it remains at the forefront of evidence-based practice, fostering the dissemination of knowledge that is critical for improving patient care and outcomes. This journal, although not open-access, provides a wealth of insights and findings relevant to professionals striving to enhance their understanding and implementation of best practices in family medicine. With a converged publication history starting in 2002, it continues to serve as an essential platform for innovative studies and discussions that shape the future of family medicine.

Journal of Primary Health Care, published by CSIRO PUBLISHING, is a premier open-access journal dedicated to advancing the field of primary health care since its inception in 2009. With an E-ISSN of 1172-6156, the journal serves as a vital platform for disseminating innovative research and practices that improve health outcomes across diverse populations. Featuring a robust H-index and notable rankings—including Q2 in Family Practice and Q3 in both Medicine (miscellaneous) and Public Health—this journal holds a significant position within the academic community, offering valuable insights to researchers, practitioners, and students alike. By providing open-access options, the Journal of Primary Health Care ensures that its findings are accessible to a global audience, promoting collaboration and knowledge sharing. As we look toward 2024, we invite contributors to be part of this dynamic conversation, addressing the critical issues in primary health care delivery and policy.

DM DISEASE-A-MONTH is a leading monthly journal published by MOSBY-ELSEVIER, dedicated to disseminating pivotal research and insights across the spectrum of general medicine. With a history spanning from 1954 to 2024, this journal has established itself as a key resource within the field, reflecting its commitment to advancing medical knowledge and practice. As evidenced by its impressive Scopus ranking—currently at #79 out of 636 in General Medicine and falling within the 87th percentile—this journal occupies a prominent position in the medical literature landscape. Although not an open-access publication, DM DISEASE-A-MONTH continues to serve a diverse audience of researchers, healthcare professionals, and medical students, providing valuable updates on recent advances in medicine and enabling its readers to stay informed about emerging trends and critical health issues. Its current Q2 category ranking in the 2023 Medical (miscellaneous) field further underscores its relevance and impact, making it an essential addition to the library of any medical practitioner or researcher.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Medicina de Familia-SEMERGEN is a pivotal Spanish journal focused on the field of family medicine and public health, published by the esteemed Elsevier. With an ISSN of 1138-3593 and an E-ISSN of 1578-8865, this journal provides a platform for researchers and practitioners to disseminate innovative studies, clinical practices, and case reports that advance the understanding of family healthcare dynamics. As of 2023, it is categorized in Q3 in Family Practice and Q4 in Public Health, reflecting its significant contributions to the respective fields. The journal is indexed in Scopus, holding ranks of 31/56 and 473/665 for family practice and public health respectively, showcasing its relevance in academic discourse. While maintaining a commitment to quality research, Medicina de Familia-SEMERGEN remains accessible for professionals seeking to improve patient outcomes in family medicine, making it an essential resource for anyone in the health domain.

AMERICAN FAMILY PHYSICIAN, published by the American Academy of Family Physicians, serves as a premier journal dedicated to the field of family practice and general medicine. With an ISSN of 0002-838X and E-ISSN of 1532-0650, this journal is instrumental in disseminating critical research findings and practical insights from 1970 through 2024. Recognized for its academic rigor, it has achieved a Q2 ranking in both Family Practice and miscellaneous Medicine categories, solidifying its position within the top tier of research publications. Researchers and practitioners will benefit from its comprehensive articles that seek to bridge the gap between clinical practice and medical research, while also addressing contemporary health challenges. Although it does not currently offer open access, the journal is widely respected for its valuable contributions to medical literature, making it essential for healthcare professionals aiming to enhance their knowledge and improve patient care.

Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.

Clinical and Experimental Pediatrics, published by the Korean Pediatric Society, is a leading open-access journal dedicated to the ever-evolving field of pediatrics. Since its inception in 2011, this esteemed journal has carved out a significant niche in the academic community, being recognized in the top quartile (Q1) of both Pediatrics and Pediatrics, Perinatology and Child Health categories as of 2023. With its publication based in South Korea, the journal aims to disseminate high-quality research and clinical studies that drive advancements in child health and pediatric care. The impact of its contributions is evidenced by its impressive Scopus rankings, being placed first in Nursing – Pediatrics and within the top 20 in Medicine – Pediatrics, Perinatology and Child Health, thereby positioning it as a critical resource for researchers, healthcare professionals, and students alike. Offering open access since 2011, Clinical and Experimental Pediatrics is committed to ensuring that innovative and vital pediatric research reaches a global audience, promoting knowledge and collaboration across borders. For anyone invested in pediatrics, this journal is an invaluable resource that shapes the future of child health.

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

Obesity Research & Clinical Practice is an esteemed journal published by ELSEVIER SCI LTD, focusing on cutting-edge research and clinical practices related to obesity and its multifaceted impact on health and wellness. With an ISSN of 1871-403X and an E-ISSN of 1878-0318, this journal serves as a vital resource for researchers and practitioners in the fields of Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. Notably, it holds a Q2 ranking in Endocrinology, Diabetes and Metabolism and a prestigious Q1 ranking in Nutrition and Dietetics for 2023, reflecting its influence and quality within the scientific community. The journal features a broad scope of research topics encompassing clinical findings, epidemiological studies, and therapeutic advancements in obesity treatment, aiming to improve health outcomes globally. Submissions are encouraged from diverse disciplines, ensuring a dynamic and multidisciplinary approach to tackling obesity-related challenges. Given its convergence of years from 2007 to 2024, Obesity Research & Clinical Practice stands as a prominent platform for disseminating valuable knowledge, insights, and groundbreaking research in this pressing area of public health.